Cardiovascular
On sale on the US market (according to the DSLD)
ProEnzol, food supplement from the US market
Cardiovascular (ProEnzol), a food supplement au code-barres 707636127711, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- ProEnzol
- Barcode
- 707636127711
- Form
- Capsule
- One serving
- « 2 Vegan Capsule(s) »
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Plant Fiber, Water
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Magnesium | Mineral | 84 mg |
| Cardiovascular Support Blend | Blend | 800 mg |
| L-Carnitine | Other substance | not stated |
| Hawthorn Flower, Leaf Extract | Plant | not stated |
| Garlic Bulb Concentrate (Allium sativum) | Plant | not stated |
| Grape Seed Extract | Plant | not stated |
| Coenzyme Q-10 | Other substance | not stated |
| Forskohlii Root Extract (Plectranthus barbatus) | Plant | not stated |
| Therapeutic Enzyme Blend | Blend | 119 mg |
| pHysioProtease | Blend | not stated |
| Nattokinase | Enzyme | not stated |
| Hemicellulase | Enzyme | not stated |
| Beta-Glucanase | Enzyme | not stated |
| Phytase | Enzyme | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Cardiovascular
Entered into DSLD on 25 February 2021. Withdrawn from the US market on 18 September 2024 (according to the DSLD).- Active ingredient added : Vitamin C (240 mg)
- Same quantity, different name: Hawthorn (leaf & flower) extract in this version; Hawthorn Flower, Leaf Extract on the displayed label (quantity not stated)
- Different quantity per serving : Magnesium: 80 mg in this version; 84 mg on the displayed label
- Different quantity per serving : Therapeutic Enzyme Blend: 116 mg in this version; 119 mg on the displayed label
Official label: Cardiovascular
Entered into DSLD on 22 May 2020. Withdrawn from the US market on 14 January 2021 (according to the DSLD).- Active ingredient added : Vitamin C (240 mg)
- Same quantity, different name: Hawthorn (leaf & flower) extract in this version; Hawthorn Flower, Leaf Extract on the displayed label (quantity not stated)
- Different quantity per serving : Cardiovascular Support Blend: 948 mg in this version; 800 mg on the displayed label
- Different quantity per serving : Magnesium: 80 mg in this version; 84 mg on the displayed label
- Different quantity per serving : Therapeutic Enzyme Blend: 116 mg in this version; 119 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- L-Carnitine
Read the warning, when it applies and the studies cited
L-CARNITINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
- Garlic Bulb Concentrate
Read the warning, when it applies and the studies cited
Garlic - Allium sativum
Route of administration: Oral
Cautions and warnings
Condition of application: Relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or protease inhibitors (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : ProEnzol
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Cardiovascular (ProEnzol): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/707636127711-cardiovascular-proenzol, updated 22 November 2024.